08 October 2018 – Grab Looking To Raise Another $1bn

Deals

Southeast Asian ride hailing platform Grab closed $2bn in funding just two months ago, but Reuters has reported that it’s looking to raise another $1bn, and that SoftBank is close to putting up half the funding.

SoftBank Vision Fund has also initiated talks to invest $500m in China-based online educational assistance platform Zuoyebang.

Traveloka, an Indonesian company that has grown into a leading holiday and travel services booking platform for Southeast Asia, is in talks with unnamed investors to raise $400m.

Elsewhere in Asia, SoftBank is reportedly in talks to invest between $200m and $250m in India-based Delhivery, one of several companies that have sprung up to feed the rapidly expanding e-commerce sector.

Enterprise cybersecurity software provider Tanium has secured $200m in a round led by Wellington Management that valued it at $6.5bn pre-money. Tanium, whose investors include Citi Ventures, has now raised about $780m altogether, and has amped up its valuation by some $1.5bn in just five months, the company having raised $175m from TPG Growth in a May round that valued it at $5bn.

Tencent and KKR’s KKR Asian Fund III have agreed to lead a $175m investment in Voyager Innovations, a fintech spinoff from telecommunications firm PLDT.

Fast fashion retailer Miniso was only founded in 2013 but has been growing at a rocket-like pace, currently standing at some 3,000 branches worldwide. Now Tencent is getting in on the act, joining Hillhouse Capital to provide $146m in funding for the company.

Education app developer Byju’s is now valued at $2bn following a $100m investment by General Atlantic India. Byju’s has raised a total of $344m from investors including Times Internet and Tencent, but the round is perhaps notable for not including SoftBank, which was said to be in talks with the company a couple of months back.

Call centre software provider Talkdesk closed a $21m series A round backed by Salesforce three years ago, but has taken a bug step forward with a $100m series B round that valued it at more than $1bn.

JHL Biotech has raised an undisclosed sum from investors including Sanoft at a $750m valuation and will put the cash toward further development of its biosimilar cancer therapies.

Drawbridge Health, a US-based medical diagnostics spinout of industrial conglomerate General Electric (GE), received an undisclosed amount of funding yesterday from Kyoto University’s venturing arm Innovation Capital (Kyoto-iCap).

Funds

Biopharmaceuticals-focused venture firm Forbion Capital Partners has closed its latest fund at $415m, a 44% upgrade on its initial target. The fund’s LPs include insurers ASR Insurances, KLP, the EU-backed European Investment Fund and the German government-owned bank KfW.

Excell Partners, a VC fund affiliated to University of Rochester, is to manage a $25m vehicle intended to spur tech activity around Rochester in upstate New York. The vehicle, dubbed Finger Lakes Forward Venture Capital (FLX) Fund, will be managed by Excell’s Technology Ventures division and funded by the New York State government.

Exits

Funding Circle has gone public in London, in a $576m initial public offering that included $184m of share sales by the online lending platform’s shareholders.

Guardant Health had a health first day as a public company, floating above its range to raise almost $238m in its IPO before seeing its share price rise by 69%.

SurveyMonkey has raised less but had a more successful IPO, floating above its range last week to raise an initial $180m.

Sutro Biopharma, a US-based cancer drug developer based on research at Stanford University and backed by pharmaceutical firms Amgen, Celgene, Eli Lilly and Merck & Co, raised $85m in its initial public offering.

NGM Biopharmaceuticals has filed to raise up to $75m in an initial public offering that will give Merck & Co and Takeda the chance to exit.

On GGV, French solar firm Neoen is aiming for a market capitalisation of €1.5bn ($1.7bn) in an initial public offering (IPO) on the Paris stock exchange.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

03 September 2018 – Uber Reaffirms Toyota Partnership

Deals

Uber has reaffirmed its partnership with Toyota, extending a pre-existing deal to include the development of an autonomous car-based ride hailing service, with Toyota investing $500m at a $72bn valuation as part of the deal.

Berkshire Hathaway has invested in One97 Communications, the Indian owner of financial services platform Paytm and e-commerce marketplace Paytm Mall.

SoftBank Vision Fund has joined forces with the international arm of ZhongAn Online P&C Insurance to launch an as-yet-unnamed joint venture with $200m in funding to sell ZhongAn’s technology to financial and healthcare companies in Asia-Pacific, including SoftBank’s portfolio companies.

Outset Medical, the mobile dialysis machine maker formerly known as Home Dialysis Plus, meanwhile added $132m in series D funding to its coffers thanks to Baxter Ventures, the Abu Dhabi state-owned Mubadala Investment Company and others.

Zhenkunhang finds corporate suppliers for $129m round

Cloudian stores $94m series E

Makeblock, the developer of a programmable robot kit that aims to teach children how to code, has closed a $44m series C round backed by Yuexiu Industrial Investment Fund, the corporate venturing arm of conglomerate Yue Xiu Enterprises, at a valuation of $367m.

Jacobio dispenses $55m series C

Funds

Singapore-based ride-hailing service Grab has added $250m to its Indonesia-focused corporate venturing unit.

Wisconn Valley Venture Fund surges with $100m

645 calls universities for $40m fund

Exits

The IPO frenzy continues as we head into the Labor Day weekend, with plenty of offerings. Meituan Dianping is still preparing its Hong Kong IPO, and sources have told Bloomberg that Tencent will buy $400m of shares in the offering as cornerstone investor.

Nio, the China-based smart electric vehicle producer backed by Baidu, Lenovo, JD.com and Tencent, made headlines earlier this year when reports emerged it was gearing up for a $2bn initial public offering.

X Financial, a China-based peer-to-peer lending platform backed by conglomerate Chow Tai Fook Enterprises, which is targeting a $250m IPO on the New York Stock Exchange.

Then we have Tubatu, a marketplace for home renovation contractors and interior designers, that is reportedly seeking $200m in its IPO on the Hong Kong Stock Exchange, which would provide an exit to 58.com.

Viomi Technology, which manufactures smart home appliances such as refrigerators and dishwashers, is meanwhile hoping to raise $150m when it lists on Nasdaq and that could prove a lucrative deal to Xiaomi, which owns nearly a fifth of Viomi (19.5% to be precise).

SurveyMonkey assesses $100m IPO

Gritstone girds itself for $80m IPO

Amgen, Celgene, Eli Lilly and Merck & Co all have reason to celebrate as their portfolio company Sutro Biopharma (whose underlying technology is based on research at Stanford University) gears up for a $75m initial public offering.

Alzheon relaunches IPO plans

Meanwhile Lyft, backed by Alphabet, Alibaba, GM, Magna International and Rakuten, is seeing an opportunity to go public before its rival Uber and has hired an advisory firm specialising in IPOs, Class V Group.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0